Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
IO Biotech, Inc. (IOBT) had Return on Equity of -66.64% for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-31.33M |
|
-- |
|
-- |
|
$26.94M |
|
$-26.94M |
|
$-3.94M |
|
$-30.89M |
|
$-30.89M |
|
$-31.33M |
|
$-31.33M |
|
$-31.33M |
|
$-31.33M |
|
$-26.94M |
|
$-26.88M |
|
65.88M |
|
65.88M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$64.95M |
|
$0.64M |
|
$2.75M |
|
$67.70M |
|
$19.49M |
|
-- |
|
$1.20M |
|
$20.68M |
|
$47.02M |
|
$47.02M |
|
$47.02M |
|
65.88M |
|
| Cash Flow Statement Financials | |
$-82.35M |
|
$-0.04M |
|
-- |
|
$143.46M |
|
$60.30M |
|
$-83.16M |
|
$6.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-82.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-66.64% |
-66.64% |
|
-46.28% |
|
-66.64% |
|
$0.71 |
|
$-1.25 |
|
$-1.25 |
|